Related Experiment Video
Updated: Jun 28, 2025

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Hippo pathway activated by circulating reactive oxygen species mediates cardiac diastolic dysfunction after acute
Xiao Han1, Quan Hong1, Fei Peng1
1Department of Nephrology, First Medical Center of Chinese People's Liberation Army (PLA) General Hospital, Chinese PLA Institute of Nephrology, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Chronic Kidney Diseases, Beijing Key Laboratory of Kidney Diseases Research, Beijing 100853, China.
Insights
Circulating reactive oxygen species (ROS) mediate cardiac dysfunction after acute kidney injury. ROS activate the Mst1/Hippo pathway, causing heart problems and offering new treatment targets for cardiorenal syndrome.
Area of Science:
- Cardiology
- Nephrology
- Biochemistry
Background:
- Acute kidney injury (AKI) can lead to cardiac dysfunction, but the mechanisms remain unclear.
- Oxidative stress is implicated in cardiorenal interactions following AKI.
Purpose of the Study:
- To investigate the role of circulating reactive oxygen species (ROS) in mediating cardiac dysfunction after renal ischemia-reperfusion injury (IRI).
- To explore the involvement of the Mst1/Hippo pathway in this process.
Main Methods:
- Induction of renal IRI in mice.
- Assessment of cardiac function, oxidative stress, ATP levels, and branched-chain amino acid (BCAA) accumulation.
- Treatment with tempol (ROS scavenger).
- In vitro studies using Mst1-knockdown and Mst1-overexpression cardiomyocytes exposed to hydrogen peroxide (H2O2).
Main Results:
- Renal IRI induced diastolic dysfunction, reduced cardiac ATP, increased oxidative stress, and BCAA accumulation.
- Circulating ROS levels increased sequentially in kidneys, circulation, and heart.
- Tempol treatment improved cardiac function and alleviated Mst1/Hippo pathway activation.
- Mst1/Hippo pathway activation in cardiomyocytes was linked to oxidative stress and BCAA dysmetabolism.
Conclusions:
- Circulating ROS following renal IRI activate the Mst1/Hippo pathway in the myocardium.
- This activation leads to cardiac oxidative stress and diastolic dysfunction.
- Findings suggest potential therapeutic strategies for cardiorenal syndrome targeting ROS and the Mst1/Hippo pathway.
Abstract:
Acute kidney injury (AKI) can cause distal cardiac dysfunction; however, the underlying mechanism is unknown. Oxidative stress is proved prominent in AKI-induced cardiac dysfunction, and a possible bridge role of oxidative-stress products in cardio-renal interaction has been reported. Therefore, this study aimed to investigate the critical role of circulating reactive oxygen species (ROS) in mediating cardiac dysfunction after bilateral renal ischemia-reperfusion injury (IRI). We observed the diastolic dysfunction in the mice following renal IRI, accompanied by reduced ATP levels, oxidative stress, and branched-chain amino acids (BCAA) accumulation in the heart. Notably, ROS levels showed a sequential increase in the kidneys, circulation, and heart. Treatment with tempol, an ROS scavenger, significantly restored cardiac diastolic function in the renal IRI mice, corroborating the bridge role of circulating ROS. Accumulating evidence has identified oxidative stress as upstream of Mst1/Hippo in cardiac injury, which could regulate the expression of downstream genes related to mitochondrial quality control, leading to lower ATP, higher ROS and metabolic disorder. To verify this, we examined the activation of the Mst1/Hippo pathway in the heart of renal IRI mice, which was alleviated by tempol treatment as well. In vitro, analysis revealed that Mst1-knockdown cardiomyocytes could be activated by hydrogen peroxide (H2O2). Analysis of Mst1-overexpression cardiomyocytes confirmed the critical role of the Mst1/Hippo pathway in oxidative stress and BCAA dysmetabolism. Therefore, our results indicated that circulating ROS following renal IRI activates the Mst1/Hippo pathway of myocardium, leading to cardiac oxidative stress and diastolic dysfunction. This finding provides new insights for the clinical exploration of improved treatment options for cardiorenal syndrome.
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure Drugs: Diuretics
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

